- General Procurement Notice
- World Bank
- Western and Central Africa
General Procurement Notice: Ministère de la Santé et de la Population (Western and Central Africa)
General procurement notice published by Ministère de la Santé et de la Population (Western and Central Africa) on 18 June 2026.
Pre-announcement
This is a general procurement pre-announcement; it is not an open invitation to tender. Bidding conditions and dates are set in the official notice the buyer publishes later.
Summary
The notice was compiled from World Bank. The source lists the project number as P508837. The title and scope text were published in French at the source and are reproduced below as published.
Key facts
- Buyer
- Ministère de la Santé et de la Population
- Country
- Western and Central Africa
- Project no.
- P508837
- Published at source
- 18 June 2026
Source text
In the source language (French): original title and scope text
Original title
General Procurement Notice — Health Security Program in Western and Central Africa - Phase III
In the source language (French)
MINISTERE DE LA SANTE ET DE LA POPULATION -*-*-*-*-*-*-*- DIRECTION DE CABINET -*-*-*-*-*-*-*- COORDINATION GENERALE DU PROJET SENI PLUS - HeSP -*-*-*-*-*-*-*- SERVICE DE PASSATION DES MARCHES -*-*-*-*-*-*-*- N ______________/MSP/DIRCAB/CGPSPHeSP/SPM.26 REPUBLIQUE CENTRAFRICAINE Unit - Dignit - Travail -*-*-*-*-*-*-*- Bangui le AVIS GENERAL DE PASSATION DES MARCHES R publique Centrafricaine Projet : PROGRAMME DE SECURITE SANITAIRE EN AFRIQUE DE L'OUEST ET DU CENTRE - PHASE III Don No: E5160 P508837 Le Gouvernement de la R publique Centrafricaine a re u un financement de la Banque mondiale d'un…Text is reproduced from the source as published; it has not been translated.
Source and licence
Source: The World Bank, World Bank Procurement Notices (Data Catalog), licensed under CC BY 4.0; summarised and arranged by TenderZoom.
Licence: Creative Commons Attribution 4.0 International (opens in a new tab)
This item is prepared automatically from the official source and contains no editorial commentary.

